Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.

   By Guest guest, May 21, 2011
   • 0 replies
   • 43 views
   • 
   • Guest
   • May 21, 2011

2. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

   By Guest guest, May 21, 2011
   • 0 replies
   • 29 views
   • 
   • Guest
   • May 21, 2011

3. lenalidomide (L) plus rituximab (R) for untreated indolent B-NHL

   By Guest guest, May 24, 2011
   • 0 replies
   • 24 views
   • 
   • Guest
   • May 24, 2011

4. Reports from Lugano conference

   By Guest guest, July 8, 2011
   • 0 replies
   • 21 views
   • 
   • Guest
   • July 8, 2011

5. Access to Safety Data

   By Guest guest, July 6, 2011
   • 0 replies
   • 27 views
   • 
   • Guest
   • July 6, 2011

6. Patients with early stage CLL: new risk stratification based on molecular profiling

   By Guest guest, July 4, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • July 4, 2011

7. Nicotinamide Blocks Proliferation and Induces Apoptosis of CLL Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network

   By Guest guest, July 4, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • July 4, 2011

8. An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma

   By Guest guest, June 29, 2011
   • 0 replies
   • 30 views
   • 
   • Guest
   • June 29, 2011

9. Chromosome Study on CLL Using CpG-ODN as Immunostimulant Agent

   By Guest guest, June 27, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • June 27, 2011

10. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas

    By Guest guest, June 29, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • June 29, 2011

11. Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

    By Guest guest, June 29, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • June 29, 2011

12. Missense Mutations Located in Structural p53 DNA-Binding Motifs

    By Guest guest, June 30, 2011
    • 0 replies
    • 23 views
    • 
    • Guest
    • June 30, 2011

13. Death receptor 4 is preferentially recruited to lipid rafts in CLL cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.

    By Guest guest, July 4, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • July 4, 2011

14. A unique case of merkel cell carcinoma and CLL presenting in a single cutaneous lesion (collision tumour).

    By Guest guest, July 4, 2011
    • 0 replies
    • 19 views
    • 
    • Guest
    • July 4, 2011

15. Nicotinamide and CLL

    By Guest guest, July 4, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • July 4, 2011

16. Nicotinamide/NAD+ and CLL

    By Guest guest, July 5, 2011
    • 0 replies
    • 23 views
    • 
    • Guest
    • July 5, 2011

17. Preserving Access to Life-Saving Medications Act

    By Guest guest, July 7, 2011
    • 0 replies
    • 41 views
    • 
    • Guest
    • July 7, 2011

18. Announcing PAL on Facebook

    By Guest guest, July 7, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • July 7, 2011

19. The 'Decline Effect' and Scientific Truth

    By Guest guest, May 15, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • May 15, 2011

20. Defending Evidence-based Medicine

    By Guest guest, May 14, 2011
    • 0 replies
    • 22 views
    • 
    • Guest
    • May 14, 2011

21. Comment on Inappropriate subgroup analysis

    By Guest guest, May 13, 2011
    • 0 replies
    • 36 views
    • 
    • Guest
    • May 13, 2011

22. Relevance of IgVH Gene Somatic Hypermutation and Interphase Cytogenetics in Lymphomatous Presentation of CLL/SLL

    By Guest guest, May 3, 2011
    • 0 replies
    • 44 views
    • 
    • Guest
    • May 3, 2011

23. Chemo IV risks (to veins)?

    By Guest guest, March 15, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • March 15, 2011

24. subgroup analysis can lead to ludicrous results

    By Guest guest, May 12, 2011
    • 0 replies
    • 48 views
    • 
    • Guest
    • May 12, 2011

25. Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial For Treatment Of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

    By Guest guest, March 24, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • March 24, 2011